Innate Pharma S.A. (EPA:IPH)
France · Delayed Price · Currency is EUR 1.540
-0.026 (-1.66%)
Jun 3, 2026, 5:35 PM CET
Innate Pharma Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -49.18 | -49.47 | -7.57 | -58.1 | -52.81 |
Depreciation & Amortization | 1.38 | 1.99 | 5.09 | 4.41 | 4.6 |
Loss (Gain) From Sale of Assets | 0.02 | 0.02 | -0.52 | - | -0.37 |
Asset Writedown & Restructuring Costs | - | - | - | 41 | - |
Loss (Gain) From Sale of Investments | -0.45 | -1.34 | -1.59 | 1.37 | -0.99 |
Stock-Based Compensation | 2.57 | 3.94 | 4.26 | 4.25 | 2.62 |
Other Operating Activities | 3.53 | -1.21 | -0.13 | 0.43 | -1.62 |
Change in Accounts Receivable | 1.65 | 51.81 | - | - | - |
Change in Accounts Payable | -0.97 | -1.01 | - | - | - |
Change in Unearned Revenue | -0.62 | -7.04 | - | - | - |
Change in Other Net Operating Assets | -10.32 | -4.11 | -32.09 | -12.5 | -9.89 |
Operating Cash Flow | -52.76 | -6.9 | -32.56 | -19.16 | -58.46 |
Capital Expenditures | -0.14 | -0.39 | -0.35 | -0.54 | -0.93 |
Sale of Property, Plant & Equipment | - | - | 0.15 | - | 0.01 |
Sale (Purchase) of Intangibles | - | - | -2 | -0.59 | -0.4 |
Investment in Securities | 7.04 | 9.59 | 22.77 | 3 | - |
Other Investing Activities | 0.39 | 0 | 0.06 | -0 | 0.41 |
Investing Cash Flow | 7.29 | 9.2 | 20.63 | 1.88 | -0.92 |
Long-Term Debt Issued | - | - | - | - | 28.7 |
Long-Term Debt Repaid | -8.91 | -8.94 | -2.36 | -2.03 | -2.07 |
Net Debt Issued (Repaid) | -8.91 | -8.94 | -2.36 | -2.03 | 26.63 |
Issuance of Common Stock | 14.98 | 2.93 | 0.4 | 0.2 | 0.5 |
Other Financing Activities | - | - | - | - | -0.31 |
Financing Cash Flow | 6.07 | -6.01 | -1.97 | -1.83 | 26.82 |
Foreign Exchange Rate Adjustments | 1.09 | -0.51 | 0.27 | -0.43 | -0.48 |
Miscellaneous Cash Flow Adjustments | - | - | 0 | 0 | -0 |
Net Cash Flow | -38.3 | -4.21 | -13.62 | -19.53 | -33.04 |
Free Cash Flow | -52.9 | -7.29 | -32.91 | -19.69 | -59.39 |
Free Cash Flow Margin | -587.40% | -36.22% | -53.39% | -34.14% | -240.40% |
Free Cash Flow Per Share | -0.59 | -0.09 | -0.41 | -0.25 | -0.75 |
Cash Interest Paid | - | - | - | - | 0.31 |
Levered Free Cash Flow | -34.07 | 17.12 | -27.07 | -32.74 | -15.02 |
Unlevered Free Cash Flow | -33.8 | 17.47 | -26.67 | -32.56 | -14.82 |
Change in Working Capital | -10.63 | 39.16 | -32.09 | -12.5 | -9.89 |